Acorda Therapeutics reported $4.56M in Cost of Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Acadia Pharmaceuticals ACAD:US USD 2.41M 277K
Acorda Therapeutics ACOR:US USD 4.56M 6.44M
Agios Pharmaceuticals AGIO:US USD 413K 104K
Amgen AMGN:US USD 1.75B 159M
Anika Therapeutics ANIK:US USD 15.49M 1.99M
Biogen BIIB:US USD 570.9M 101.4M
Biomarin Pharmaceutical BMRN:US USD 127.29M 11M
Cara Therapeutics CARA:US USD 2.13M 925K
Clovis Oncology CLVS:US USD 8.61M 607K
Gilead Sciences GILD:US USD 1.4B 1000K
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Halozyme Therapeutics HALO:US USD 42.12M 5.2M
Heron Therapeutics HRTX:US USD 14.72M 1.46M
Insmed INSM:US USD 13.07M 402K
Ligand Pharmaceuticals LGND:US USD 21.61M 7.46M
Mannkind MNKD:US USD 16.12M 1.34M
Merck MRK:GR EUR 2.28B 137M
Moderna Inc MRNA:US USD 1.92B 818M
Neurocrine Biosciences NBIX:US USD 7.7M 1.6M
Novartis NOVN:VX USD 3.84B 180M
Pfizer PFE:US USD 9.82B 3.73B
Teva Pharmaceutical TEVA:IT USD 1.78B 101M
Ultragenyx Pharmaceutical RARE:US USD 5.32M 3.31M
Vertex Pharmaceuticals VRTX:US USD 283.3M 6.1M